Vigabatrin Tablet
Product Images NDC 0054-0652

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 0054-0652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vigabatrin Structural Formula (Image 01)

Vigabatrin Structural Formula (Image 01)
Chemical structure diagram of vigabatrin, showing its molecular framework with functional groups including an amino group, a vinyl group, and a carboxylic acid group.*
FDA Label Image

Figure-01 (Image 02)

Figure-01 (Image 02)
A line graph displaying the percentage reduction in seizure frequency on the vertical axis versus the percentage of patients on the horizontal axis. It compares seizure frequency reduction among four groups: placebo, 1g/day, 3g/day, and 6g/day Vigabatrin (VGB) dosages. The graph shows improvement above the zero line and worsening below it.*
FDA Label Image

Figure-02 (Image 03)

Figure-02 (Image 03)
A cumulative distribution plot depicting the percentage reduction in seizure frequency among patients. The x-axis represents the percentage of patients, while the y-axis shows the percent reduction in seizures, ranging from -100% to +100%. Two curves compare 3 g/day Vigabatrin (VGB) treatment versus placebo, with annotations indicating improvement and worsening in seizure frequency.*
FDA Label Image

Vigabatrin-tabs-500mg-100s-label (Image 04)

Vigabatrin-tabs-500mg-100s-label (Image 04)
Vigabatrin Tablets, USP 500 mg oral tablets packaging label from Hikma Pharmaceuticals USA Inc. The label indicates a quantity of 100 tablets and includes storage instructions at 20° to 25°C along with a note to dispense the medication guide with each prescription. The label features the NDC 0054-0652 and the Hikma logo in red.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.